Results of early trials presented at the European Society of Medical Oncology congress suggest a new highly effective drug combination treatment for women in ovarian cancer, "shown to shrink tumours in half of patients with an advanced form of the disease." The unique drug combination blocks cancer cell growth signals and is an alternative treatment for ovarian cancer that does not respond well to chemotherapy or hormone therapy.
To learn more about this trial, click here.
No comments:
Post a Comment